Skip to main content

Want a detailed portfolio tracker?

Ascentage Pharma Group International (AAPG) P/E (2025 - 2026)

Ascentage Pharma Group International (AAPG) P/E from Jan 24, 2025 to Jun 3, 2026. The TTM Ascentage Pharma Group International (AAPG) P/E is -5.58. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ascentage Pharma Group International (AAPG)

YearP/EChange
2026-5.58-31.96%
2025-8.20N/A

Comparison Ascentage Pharma Group International (AAPG) P/E with competitors

Ascentage Pharma Group International (AAPG) P/E is -5.58.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.10-101.83%
ENLVEnlivex Therapeutics Ltd0.15-102.69%
FGENFibroGen Inc0.24-104.30%
TRAWTraws Pharma Inc0.47-108.48%
FBIOFortress Biotech Inc0.71-112.66%
CHRSCoherus Biosciences Inc0.98-117.54%
ORMPOramed Pharmaceuticals Inc1.47-126.42%
AGENAgenus Inc2.05-136.73%
VIVSVivoSim Labs Inc2.54-145.47%
INVAInnoviva Inc3.19-157.17%
CRMDCorMedix Inc3.65-165.37%
ABEOAbeona Therapeutics Inc4.20-175.39%
VXRTVaxart Inc4.26-176.41%
CVACCureVac N.V.4.45-179.71%
SRPTSarepta Therapeutics Inc4.62-182.91%
GLPGGalapagos NV4.86-187.12%
RIGLRigel Pharmaceuticals4.92-188.20%
ZVRAZevra Therapeutics Inc4.97-189.18%
ABUSArbutus Biopharma Corp5.69-202.09%
CGENCompugen Ltd7.38-232.39%
AUPHAurinia Pharmaceuticals Inc9.25-265.88%
ACADAcadia Pharmaceuticals Inc9.59-271.91%
OMEROmeros Corporation9.88-277.21%
PLXProtalix BioTherapeutics Inc9.91-277.67%
SPROSpero Therapeutics Inc10.73-292.47%
ADMAAdma Biologics Inc11.33-303.16%
SVASinovac Biotech Ltd11.44-305.05%
TBPHTheravance Biopharma Inc11.78-311.15%
HRMYHarmony Biosciences Holdings Inc12.18-318.39%
TGTXTG Therapeutics Inc13.18-336.30%
INCYIncyte Corp13.38-339.94%
SABSSAB Biotherapeutics Inc14.06-352.05%
XOMAXOMA Corp14.95-367.97%
REGNRegeneron Pharmaceuticals Inc14.98-368.59%
PBYIPuma Biotechnology Inc15.05-369.85%
EXELExelixis Inc15.79-383.20%
NAGENiagen Bioscience Inc16.35-393.24%
CPRXCatalyst Pharmaceuticals Inc17.34-410.99%
MDXGMimedx Group Inc17.38-411.54%
ARGXArgen X SE23.07-513.67%
HALOHalozyme Therapeutics Inc23.20-515.98%
XOMAOXOMA Corp25.34-554.43%
VRTXVertex Pharmaceuticals Inc25.66-560.00%
XOMAPXOMA Corp25.67-560.26%
CTMXCytomX Therapeutics Inc25.70-560.76%
ASNDAscendis Pharma A/S26.35-572.52%
RPRXRoyalty Pharma plc - Class A27.50-592.99%
SLNOSoleno Therapeutics Inc29.02-620.24%
LGNDLigand Pharmaceuticals Inc - Class B30.19-641.24%
BMRNBiomarin Pharmaceutical Inc37.51-772.50%
APLSApellis Pharmaceuticals Inc39.02-799.64%
KRYSKrystal Biotech Inc39.70-811.77%
GMABGenmab40.20-820.84%
ONCBeiGene Ltd67.03-1301.78%
TECHBio-Techne Corp68.59-1329.90%
VCELVericel Corp80.63-1545.67%
PHARPharming Group N.V.87.74-1673.17%
ALNYAlnylam Pharmaceuticals Inc124.93-2340.04%
TLXTelix Pharmaceuticals Ltd139.89-2608.22%
CORTCorcept Therapeutics Inc158.39-2939.90%